Aridis Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARDS and other ETFs, options, and stocks.About ARDS
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-101, AR-501, AR-712, AR-701, AR-401, AR-105 and AR-201.
CEOVu L. Truong
CEOVu L. Truong
Employees34
Employees34
HeadquartersLos Gatos, California
HeadquartersLos Gatos, California
Founded2003
Founded2003
Employees34
Employees34
ARDS Key Statistics
Market cap13.86M
Market cap13.86M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume4.65M
Average volume4.65M
High today—
High today—
Low today—
Low today—
Open price$0.6701
Open price$0.6701
Volume5.33K
Volume5.33K
52 Week high$2.94
52 Week high$2.94
52 Week low$0.5722
52 Week low$0.5722
ARDS News
Yahoo Finance 7d
Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia - Yahoo FinanceAridis Pharmaceuticals, Inc. LOS GATOS, Calif, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced top-line results f...
ARDS Earnings
-$1.94
-$1.29
-$0.65
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 30, After Hours
ActualExpected Mar 30, After Hours